Manulife (Manufacturers Life Insurance)’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-12,895
| Closed | -$169K | – | 2816 |
|
|
2025
Q4 | $169K | Sell |
12,895
-1,112
| -8% | -$13.3K | ﹤0.01% | 2591 |
|
|
2025
Q3 | $102K | Sell |
14,007
-2,868
| -17% | -$19.4K | ﹤0.01% | 2775 |
|
|
2025
Q2 | $90.5K | Sell |
16,875
-468
| -3% | -$2.27K | ﹤0.01% | 2776 |
|
|
2025
Q1 | $92.6K | Buy |
17,343
+495
| +3% | +$3.46K | ﹤0.01% | 2708 |
|
|
2024
Q4 | $151K | Sell |
16,848
-355
| -2% | -$3.77K | ﹤0.01% | 2716 |
|
|
2024
Q3 | $189K | Sell |
17,203
-471
| -3% | -$5.24K | ﹤0.01% | 2687 |
|
|
2024
Q2 | $161K | Buy |
17,674
+518
| +3% | +$5.06K | ﹤0.01% | 2684 |
|
|
2024
Q1 | $241K | Buy |
17,156
+2,231
| +15% | +$27.8K | ﹤0.01% | 2504 |
|
|
2023
Q4 | $115K | Buy |
14,925
+4,317
| +41% | +$23.9K | ﹤0.01% | 2774 |
|
|
2023
Q3 | $79.1K | Hold |
10,608
| – | – | ﹤0.01% | 2871 |
|
|
2023
Q2 | $88.4K | Buy |
+10,608
| New | +$122K | ﹤0.01% | 2883 |
|
|
2020
Q4 | – | Sell |
-2,062
| Closed | -$77K | – | 2989 |
|
|
2020
Q3 | $77K | Hold |
2,062
| – | – | ﹤0.01% | 2849 |
|
|
2020
Q2 | $86K | Buy |
+2,062
| New | +$73.4K | ﹤0.01% | 2790 |
|
|
2017
Q3 | – | Sell |
-13
| Closed | -$1K | – | 4239 |
|
|
2017
Q2 | $1K | Sell |
13
-1
| -7% | -$83 | ﹤0.01% | 4193 |
|
|
2017
Q1 | $1K | Hold |
14
| – | – | ﹤0.01% | 4011 |
|
|
2016
Q4 | $3K | Hold |
14
| – | – | ﹤0.01% | 4023 |
|
|
2016
Q3 | $5K | Hold |
14
| – | – | ﹤0.01% | 3856 |
|
|
2016
Q2 | $3K | Sell |
14
-20
| -59% | -$6.03K | ﹤0.01% | 3912 |
|
|
2016
Q1 | $9K | Buy |
+34
| New | +$11.7K | ﹤0.01% | 3651 |
|
Manulife (Manufacturers Life Insurance)'s ATXS Position: Q1 2026 in Review
Manulife (Manufacturers Life Insurance) sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 12,895 shares — an estimated $169K sold.
Manulife (Manufacturers Life Insurance) first reported a position in ATXS in Q1 2016 and held it in 19 quarters. The position peaked at $241K in Q1 2024. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.
- Manulife (Manufacturers Life Insurance) reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 12,895 Astria Therapeutics shares in Q1 2026, an estimated $169K.
- Manulife (Manufacturers Life Insurance) first reported a position in Astria Therapeutics in Q1 2016 and held it in 19 quarters.
- Manulife (Manufacturers Life Insurance)'s Astria Therapeutics position peaked at $241K in Q1 2024.
- 0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.